Agenus announces appointment of dr. jennifer buell to its board of directors

Lexington, mass.--(business wire)--agenus inc. (“agenus”) (nasdaq: agen), a leader in developing novel immunological agents to treat various cancers, is pleased to announce the appointment of dr. jennifer buell to its board of directors, on june 11, 2024, effective immediately. dr. buell will maintain her active and ongoing role as the president and ceo of mink therapeutics, in addition to her responsibilities as chairman of the executive council at agenus. her continued leadership at mink ensu.
AGEN Ratings Summary
AGEN Quant Ranking